In 2022, Michael C. Kaufmann earned $3.40M in total compensation at Cardinal Health, including $1.20M salary, $500.00K bonus and $1.50M in stock. Most recently acquired 132,857 shares in Aug 2022. Currently holds stock worth $135.34M. Has donated $913.46K in stock to charitable causes. Led Cardinal Health as CEO for 4 years.
Compensation History
Annual executive compensation data for Michael C. Kaufmann, including salary, bonuses, and stock awards.
Year
2022
Total Compensation
$3.40M
Salary
$1.20M
Bonus
$500.00K
Other
$200.00K
Salary
$1.20MBoard Justification
The compensation philosophy aligns with company performance, peer benchmarking, and retention strategies to attract and retain top executive talent.
Bonus
$500.00KBoard Justification
The bonus is based on the company's performance metrics including revenue growth and operational efficiency for the year 2022.
Other Compensation
$200.00KBoard Justification
Other compensation includes retirement contributions and health benefits paid in 2022.
Restricted Stock
Board Justification
30,000 shares of RSUs vested in 2022 as part of the long-term incentive plan, based on performance criteria being met.
Performance Metrics
Performance metrics include revenue growth, EBITDA margin, and total shareholder return.
Michael C. Kaufmann
Ex-CEO of Cardinal Health
Education
Not specified
Field of Expertise
Finance & Banking - Finance
Sector of Economy
Healthcare
Born
January 1, 1965 - 60 years ago
CEO of Cardinal Health for
4 years 8 months (Jan 2018 - Sep 2022)
Previous Experience
Chief Financial Officer of Cardinal Health, Inc. since November 2014; Chief Executive Officer of Pharmaceutical segment from August 2009 to November 2014.
Other Cardinal Health CEOs
Holdings
Track Michael C. Kaufmann's stock holdings and portfolio value over time.
Total Stock Sold
$42.41M
$42.41M
692,902 CAH shares
What if they kept their stock?
If Michael C. Kaufmann didn't sell their stock, today they would have:
Extra CAH692,902 shares worth $137.80M.
This is 224.97% and $95.40M more than what they got when they sold the stock.
Charitable Transactions
4,593 shares
CAH
Recent Charitable Transactions
3,500 shares
CAH
Aug 8, 2017
Charity
153 shares
CAH
Aug 4, 2016
Charity
340 shares
CAH
Aug 4, 2015
Charity
300 shares
CAH
Jan 23, 2013
Charity
300 shares
CAH
Jun 30, 2012
Charity
Insider Trading
Michael C. Kaufmann's recent stock transactions, purchases, and sales filed with the SEC.
132,857 shares
CAH
Aug 9, 2022
Received
85,106 shares
CAH
Aug 15, 2021
Received
98,866 shares
CAH
Aug 3, 2021
Received
74,516 shares
CAH
Aug 15, 2020
Received
2,717 shares
CAH
Aug 3, 2020
Received
95,238 shares
CAH
Aug 15, 2019
Received
63,694 shares
CAH
Jun 28, 2019
Received
71,642 shares
CAH
Aug 15, 2018
Received
$1.37M
CAH at $73.90/share
Jan 22, 2018
Sale
49,188 shares
CAH
Nov 8, 2017
Received
Rivals
Compare Michael C. Kaufmann with competitor CEOs and industry peers.
Brian S. Tyler
CEO of McKesson
2023 Compensation
Stock
$53.90M
Salary
$1.49M
Bonus
$0.00
Other
$864.73K
Total Holdings
$230.10K
Kevin Sayer
CEO of DexCom
2023 Compensation
Stock
$13.51M
Salary
$1.09M
Bonus
$1.99M
Other
$143.54K
Total Holdings
$26.32M
Joseph W. Dziedzic
CEO of Integer Holdings
2022 Compensation
Stock
$0.00
Salary
$1.23M
Bonus
$0.00
Other
$97.75K
Total Holdings
$77.20M
Steven H. Collis
CEO of Cencora
2023 Compensation
Stock
$0.00
Salary
$1.40M
Bonus
$3.23M
Other
$379.52K
Total Holdings
$242.12M
Fred P. Lampropoulos
Founder and CEO of Merit Medical Systems
2023 Compensation
Stock
$2.77M
Salary
$1.89M
Bonus
$1.34M
Other
$8.70K
Total Holdings
$38.99M